MLNM,
Chase H&Q 19th Annual Healthcare Conference to Webcast Millennium Pharmaceuticals Presentation
CAMBRIDGE, Mass., Jan 5, 2001 /PRNewswire via COMTEX/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM chart, msgs) announced today that its presentation to the Chase H&Q Healthcare Conference will be webcast live and may be accessed under the "Events" tab at www.chasehq.com.
(Photo:http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )
Mark Levin, chairman and chief executive officer of Millennium, will provide an overview of the company and review corporate goals for 2001. His presentation will be delivered at 3:30 p.m. (Pacific Time) on Wednesday, January 10, from the Grand Ballroom of the Westin St. Francis Hotel in San Francisco.
Millennium, a leading biopharmaceutical company, applies its comprehensive and integrated science and technology platform for the discovery and development of breakthrough therapeutic and predictive medicine products, with a goal of delivering personalized medicine. Through the industrialization of this gene-to-patient platform, Millennium is also striving to accelerate the process of drug discovery and development. Headquartered in Cambridge, Mass., Millennium currently employs more than 1,200 people.
Editor's Note: This release is available on Millennium's website at www.millennium.com
Source: Millennium Pharmaceuticals, Inc.
Contact:
Gina Brazier of Millennium Pharmaceuticals, Inc., 617-551-3611
/Photo: NewsCom: newscom.com
AP Archive: photoarchive.ap.org
PRN Photo Desk, 888-776-6555 or 201-369-3467
/Company News On-Call: prnewswire.com or fax,
800-758-5804, ext. 114562
URL: mlnm.com
M |
